Form 4: Cannabis Sativa, Inc. CEO David Tobias Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4


David Tobias, CEO of Cannabis Sativa, Inc., reports multiple transactions involving the acquisition and disposal of common stock between April 18, 2022, and May 16, 2022.

Summary

  • David Tobias, the CEO of Cannabis Sativa, Inc. (CBDS), filed a Form 4 detailing changes in his beneficial ownership of the company's common stock.
  • Between April 18, 2022, and May 16, 2022, Tobias sold shares of common stock in multiple transactions at prices ranging from $0.1031 to $0.2 per share.
  • On April 28, 2022, Tobias acquired 131,880 shares through a conversion from preferred to common stock.
  • After these transactions, Tobias directly owns 3,138,533 shares of Cannabis Sativa, Inc.
  • The filing indicates that some transactions were sales (denoted by 'S') and one was an acquisition (denoted by 'A') resulting from a conversion of preferred stock to common stock (denoted by 'J').

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative due to the consistent selling of shares by the CEO, offset somewhat by the conversion of preferred stock. This suggests a cautious outlook, but not necessarily a dire one.

Positives

  • The conversion of preferred stock to common stock on April 28, 2022, increased Tobias's holdings by 131,880 shares.

Negatives

  • Tobias sold a significant number of shares over the reporting period, potentially indicating a lack of confidence in the company's short-term prospects.

Risks

  • Continued selling activity by the CEO could negatively impact investor sentiment and the company's stock price.
  • The fluctuations in the stock price during the reporting period suggest potential volatility.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. Monitoring these filings can offer insights into management's perspective on the company's valuation and future prospects within the cannabis industry.

Comparison to Industry Standards

  • Comparing the CEO's trading activity to that of executives at similar cannabis companies like Canopy Growth Corporation (CGC) or Aurora Cannabis (ACB) could provide a benchmark for assessing the significance of these transactions.
  • For example, if executives at CGC or ACB are primarily buying shares, while Tobias is selling, it might suggest a less optimistic outlook for Cannabis Sativa, Inc. relative to its peers.
  • Analyzing the ratio of insider buying to selling across the cannabis industry can also provide context for these transactions.

Stakeholder Impact

  • Shareholders may be concerned about the CEO's selling activity, potentially leading to a decrease in stock value.
  • Employees might perceive the selling activity as a lack of confidence in the company's future, affecting morale.
  • Creditors may scrutinize the company's financial stability more closely given the insider selling.

Key Dates

DateDescription
04/18/2022First reported transaction date; sale of 3,987 shares at $0.185.
04/19/2022Sale of 3,285 shares at $0.1969.
04/20/2022Sale of 1,552 shares at $0.2.
04/21/2022Sale of 27,058 shares at $0.1736.
04/22/2022Sale of 6,523 shares at $0.165.
04/25/2022Sale of 3,778 shares at $0.18.
04/26/2022Sale of 5,516 shares at $0.1681.
04/27/2022Sale of 4,143 shares at $0.1637.
04/28/2022Acquisition of 131,880 shares via preferred to common stock conversion and sale of 3,428 shares at $0.17.
05/04/2022Sale of 1,257 shares at $0.165.
05/05/2022Sale of 819 shares at $0.1635.
05/06/2022Sale of 1,448 shares at $0.1635.
05/09/2022Sale of 1,154 shares at $0.1355.
05/10/2022Sale of 8,737 shares at $0.1401.
05/11/2022Sale of 5,938 shares at $0.1031 and 700 shares at $0.14.
05/12/2022Sale of 5,451 shares at $0.12.
05/13/2022Sale of 4,525 shares at $0.1201.
05/16/2022Last reported transaction date; sale of 5,372 shares at $0.137.
02/27/2024Signature date of the reporting person.

Keywords

Form 4, beneficial ownership, David Tobias, Cannabis Sativa, Inc., CBDS, common stock, stock sales, stock acquisition, CEO

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.